This report aims to provide a comprehensive presentation of the global market for Cancer Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Pain. This report contains market size and forecasts of Cancer Pain in global, including the following market information:
Global Cancer Pain Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Pain market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Opioids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Pain include BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson?Johnson, Meda Pharmaceuticals and Orexo, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Pain Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Pain Market Segment Percentages, by Type, 2022 (%)
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Global Cancer Pain Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Pain Market Segment Percentages, by Application, 2022 (%)
Radiotherapy
Chemotherapy
Hormone Therapy
Others
Global Cancer Pain Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Pain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson?Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Pain, market overview.
Chapter 2: Global Cancer Pain market size in revenue.
Chapter 3: Detailed analysis of Cancer Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Pain Overall Market Size
2.1 Global Cancer Pain Market Size: 2022 VS 2029
2.2 Global Cancer Pain Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Pain Players in Global Market
3.2 Top Global Cancer Pain Companies Ranked by Revenue
3.3 Global Cancer Pain Revenue by Companies
3.4 Top 3 and Top 5 Cancer Pain Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Pain Players in Global Market
3.6.1 List of Global Tier 1 Cancer Pain Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Pain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Pain Market Size Markets, 2022 & 2029
4.1.2 Opioids
4.1.3 Non-Steroidal Anti-Inflammatory Drugs
4.1.4 Others
4.2 By Type - Global Cancer Pain Revenue & Forecasts
4.2.1 By Type - Global Cancer Pain Revenue, 2018-2023
4.2.2 By Type - Global Cancer Pain Revenue, 2024-2029
4.2.3 By Type - Global Cancer Pain Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Pain Market Size, 2022 & 2029
5.1.2 Radiotherapy
5.1.3 Chemotherapy
5.1.4 Hormone Therapy
5.1.5 Others
5.2 By Application - Global Cancer Pain Revenue & Forecasts
5.2.1 By Application - Global Cancer Pain Revenue, 2018-2023
5.2.2 By Application - Global Cancer Pain Revenue, 2024-2029
5.2.3 By Application - Global Cancer Pain Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Pain Market Size, 2022 & 2029
6.2 By Region - Global Cancer Pain Revenue & Forecasts
6.2.1 By Region - Global Cancer Pain Revenue, 2018-2023
6.2.2 By Region - Global Cancer Pain Revenue, 2024-2029
6.2.3 By Region - Global Cancer Pain Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Pain Revenue, 2018-2029
6.3.2 US Cancer Pain Market Size, 2018-2029
6.3.3 Canada Cancer Pain Market Size, 2018-2029
6.3.4 Mexico Cancer Pain Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Pain Revenue, 2018-2029
6.4.2 Germany Cancer Pain Market Size, 2018-2029
6.4.3 France Cancer Pain Market Size, 2018-2029
6.4.4 U.K. Cancer Pain Market Size, 2018-2029
6.4.5 Italy Cancer Pain Market Size, 2018-2029
6.4.6 Russia Cancer Pain Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Pain Market Size, 2018-2029
6.4.8 Benelux Cancer Pain Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Pain Revenue, 2018-2029
6.5.2 China Cancer Pain Market Size, 2018-2029
6.5.3 Japan Cancer Pain Market Size, 2018-2029
6.5.4 South Korea Cancer Pain Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Pain Market Size, 2018-2029
6.5.6 India Cancer Pain Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Pain Revenue, 2018-2029
6.6.2 Brazil Cancer Pain Market Size, 2018-2029
6.6.3 Argentina Cancer Pain Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Pain Revenue, 2018-2029
6.7.2 Turkey Cancer Pain Market Size, 2018-2029
6.7.3 Israel Cancer Pain Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Pain Market Size, 2018-2029
6.7.5 UAE Cancer Pain Market Size, 2018-2029
7 Cancer Pain Companies Profiles
7.1 BioDelivery Science
7.1.1 BioDelivery Science Company Summary
7.1.2 BioDelivery Science Business Overview
7.1.3 BioDelivery Science Cancer Pain Major Product Offerings
7.1.4 BioDelivery Science Cancer Pain Revenue in Global Market (2018-2023)
7.1.5 BioDelivery Science Key News & Latest Developments
7.2 ProStrakan Group
7.2.1 ProStrakan Group Company Summary
7.2.2 ProStrakan Group Business Overview
7.2.3 ProStrakan Group Cancer Pain Major Product Offerings
7.2.4 ProStrakan Group Cancer Pain Revenue in Global Market (2018-2023)
7.2.5 ProStrakan Group Key News & Latest Developments
7.3 Teva pharmaceuticals
7.3.1 Teva pharmaceuticals Company Summary
7.3.2 Teva pharmaceuticals Business Overview
7.3.3 Teva pharmaceuticals Cancer Pain Major Product Offerings
7.3.4 Teva pharmaceuticals Cancer Pain Revenue in Global Market (2018-2023)
7.3.5 Teva pharmaceuticals Key News & Latest Developments
7.4 Eli-Lilly
7.4.1 Eli-Lilly Company Summary
7.4.2 Eli-Lilly Business Overview
7.4.3 Eli-Lilly Cancer Pain Major Product Offerings
7.4.4 Eli-Lilly Cancer Pain Revenue in Global Market (2018-2023)
7.4.5 Eli-Lilly Key News & Latest Developments
7.5 Grunenthal Group
7.5.1 Grunenthal Group Company Summary
7.5.2 Grunenthal Group Business Overview
7.5.3 Grunenthal Group Cancer Pain Major Product Offerings
7.5.4 Grunenthal Group Cancer Pain Revenue in Global Market (2018-2023)
7.5.5 Grunenthal Group Key News & Latest Developments
7.6 GW Pharmaceuticals
7.6.1 GW Pharmaceuticals Company Summary
7.6.2 GW Pharmaceuticals Business Overview
7.6.3 GW Pharmaceuticals Cancer Pain Major Product Offerings
7.6.4 GW Pharmaceuticals Cancer Pain Revenue in Global Market (2018-2023)
7.6.5 GW Pharmaceuticals Key News & Latest Developments
7.7 Johnson?Johnson
7.7.1 Johnson?Johnson Company Summary
7.7.2 Johnson?Johnson Business Overview
7.7.3 Johnson?Johnson Cancer Pain Major Product Offerings
7.7.4 Johnson?Johnson Cancer Pain Revenue in Global Market (2018-2023)
7.7.5 Johnson?Johnson Key News & Latest Developments
7.8 Meda Pharmaceuticals
7.8.1 Meda Pharmaceuticals Company Summary
7.8.2 Meda Pharmaceuticals Business Overview
7.8.3 Meda Pharmaceuticals Cancer Pain Major Product Offerings
7.8.4 Meda Pharmaceuticals Cancer Pain Revenue in Global Market (2018-2023)
7.8.5 Meda Pharmaceuticals Key News & Latest Developments
7.9 Orexo
7.9.1 Orexo Company Summary
7.9.2 Orexo Business Overview
7.9.3 Orexo Cancer Pain Major Product Offerings
7.9.4 Orexo Cancer Pain Revenue in Global Market (2018-2023)
7.9.5 Orexo Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Cancer Pain Major Product Offerings
7.10.4 Sanofi Cancer Pain Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 WEX Pharmaceuticals
7.11.1 WEX Pharmaceuticals Company Summary
7.11.2 WEX Pharmaceuticals Business Overview
7.11.3 WEX Pharmaceuticals Cancer Pain Major Product Offerings
7.11.4 WEX Pharmaceuticals Cancer Pain Revenue in Global Market (2018-2023)
7.11.5 WEX Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Pain Market Opportunities & Trends in Global Market
Table 2. Cancer Pain Market Drivers in Global Market
Table 3. Cancer Pain Market Restraints in Global Market
Table 4. Key Players of Cancer Pain in Global Market
Table 5. Top Cancer Pain Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Pain Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Pain Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Pain Product Type
Table 9. List of Global Tier 1 Cancer Pain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Pain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Pain Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Pain Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Pain Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Pain Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Pain Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Pain Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Pain Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Pain Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Pain Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Pain Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Pain Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Pain Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Pain Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Pain Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Pain Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Pain Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Pain Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Pain Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Pain Revenue, (US$, Mn), 2024-2029
Table 30. BioDelivery Science Company Summary
Table 31. BioDelivery Science Cancer Pain Product Offerings
Table 32. BioDelivery Science Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 33. BioDelivery Science Key News & Latest Developments
Table 34. ProStrakan Group Company Summary
Table 35. ProStrakan Group Cancer Pain Product Offerings
Table 36. ProStrakan Group Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 37. ProStrakan Group Key News & Latest Developments
Table 38. Teva pharmaceuticals Company Summary
Table 39. Teva pharmaceuticals Cancer Pain Product Offerings
Table 40. Teva pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 41. Teva pharmaceuticals Key News & Latest Developments
Table 42. Eli-Lilly Company Summary
Table 43. Eli-Lilly Cancer Pain Product Offerings
Table 44. Eli-Lilly Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 45. Eli-Lilly Key News & Latest Developments
Table 46. Grunenthal Group Company Summary
Table 47. Grunenthal Group Cancer Pain Product Offerings
Table 48. Grunenthal Group Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 49. Grunenthal Group Key News & Latest Developments
Table 50. GW Pharmaceuticals Company Summary
Table 51. GW Pharmaceuticals Cancer Pain Product Offerings
Table 52. GW Pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 53. GW Pharmaceuticals Key News & Latest Developments
Table 54. Johnson?Johnson Company Summary
Table 55. Johnson?Johnson Cancer Pain Product Offerings
Table 56. Johnson?Johnson Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson?Johnson Key News & Latest Developments
Table 58. Meda Pharmaceuticals Company Summary
Table 59. Meda Pharmaceuticals Cancer Pain Product Offerings
Table 60. Meda Pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 61. Meda Pharmaceuticals Key News & Latest Developments
Table 62. Orexo Company Summary
Table 63. Orexo Cancer Pain Product Offerings
Table 64. Orexo Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 65. Orexo Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Cancer Pain Product Offerings
Table 68. Sanofi Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. WEX Pharmaceuticals Company Summary
Table 71. WEX Pharmaceuticals Cancer Pain Product Offerings
Table 72. WEX Pharmaceuticals Cancer Pain Revenue (US$, Mn) & (2018-2023)
Table 73. WEX Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Cancer Pain Segment by Type in 2022
Figure 2. Cancer Pain Segment by Application in 2022
Figure 3. Global Cancer Pain Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Pain Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Pain Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Pain Revenue in 2022
Figure 8. By Type - Global Cancer Pain Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Pain Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Pain Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Pain Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Pain Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Pain Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Pain Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Pain Revenue Market Share, 2018-2029
Figure 16. US Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Pain Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Pain Revenue Market Share, 2018-2029
Figure 28. China Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Pain Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Pain Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Pain Revenue, (US$, Mn), 2018-2029
Figure 41. BioDelivery Science Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ProStrakan Group Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli-Lilly Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Grunenthal Group Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GW Pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson?Johnson Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Meda Pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Orexo Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. WEX Pharmaceuticals Cancer Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
